Sage Journals: Discover world-class research

Abstract

Keywords

Sclerotherapy venous disease foam sclerotherapy endovenous technique chronic venous insufficiency

Get full access to this article

View all access options for this article.

References

Kabnick

Jimenez

Coogan

, et al. Comparative effectiveness of non-compounded polidocanol 1% endovenous microfoam (Varithena) ablation versus endovenous thermal ablation utilizing a systematic review and network meta-analysis. J Vasc Surg Venous Lymphat Disord 2024; 12(6): 101896.

Todd

Daniel

John

, et al. 1% Polidocanol Endovenous Microfoam (Varithena^TM) for the Treatment of Chronic Venous Disease. A position statement from the American Vein and Lymphatic Society. 2024; 26: 2683555241309808.

Varithena full prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021201s002lbl.pdf

From innovation to standard: Proprietary foam Sclerotherapy’s rise as a pillar in venous disease treatment

Abstract

Keywords

Get full access to this article

References